The latest tariffs imposed by the US on India’s generic medicines could have severe consequences for the Indian pharmaceutical industry and global healthcare.
The latest tariffs imposed by the US on India’s generic medicines could have severe consequences for the Indian pharmaceutical industry and global healthcare.